NASDAQ:IMAC

IMAC Stock Forecast, Price & News

$0.74

-0.09 (-10.84 %)

(As of 10/19/2020 12:00 AM ET)

Add

Compare

Today's Range

$0.73

Now: $0.74▼

$0.84

50-Day Range

$0.70

MA: $0.82▼

$1.02

52-Week Range

$0.42

Now: $0.74▼

$4.95

Volume275,688 shs

Average Volume521,115 shs

Market Capitalization$8.76 million

P/E RatioN/A

Dividend YieldN/A

Beta-3.18

IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of March 26, 2020, the company owned or managed 14 outpatient clinics in Kentucky, Missouri, Tennessee, and Illinois. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.

Beat the Market (BTM) Rank^™

3.3 Analyst's Opinion

Consensus Rating
IMAC has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $4.50, IMAC has a forecasted upside of 508.1% from its current price of $0.74.
Amount of Analyst Coverage
IMAC has received no research coverage in the past 90 days.

2.2 Community Rank

Outperform Votes
IMAC has received 68 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
IMAC has received 84 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
IMAC has received 55.26% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about IMAC and other stocks. Vote “Outperform” if you believe IMAC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IMAC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
IMAC does not currently pay a dividend.
Dividend Growth
IMAC does not have a long track record of dividend growth.

3.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, IMAC insiders have bought more of their company's stock than they have sold. Specifically, they have bought $3,900.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 21.30% of the stock of IMAC is held by insiders.
Percentage Held by Institutions
Only 0.73% of the stock of IMAC is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of IMAC is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of IMAC is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
IMAC has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.82 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Specialty outpatient clinics, not elsewhere classified

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:IMAC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.imacregeneration.com

Phone844-266-4622

Employees108

Debt

Debt-to-Equity Ratio0.16

Current Ratio0.56

Quick Ratio0.56

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$15.13 million

Price / Sales0.58

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.93 per share

Price / Book0.80

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-6,500,000.00

Net Margins-46.65%

Return on Equity-85.82%

Return on Assets-31.43%

Miscellaneous

Outstanding Shares11,840,000

Market Cap$8.76 million

Next Earnings Date11/12/2020 (Estimated)

OptionableNot Optionable

$0.74

-0.09 (-10.84 %)

(As of 10/19/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive IMAC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC (NASDAQ:IMAC) Frequently Asked Questions

How has IMAC's stock been impacted by Coronavirus?

IMAC's stock was trading at $0.82 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IMAC shares have decreased by 9.8% and is now trading at $0.74.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of IMAC?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for IMAC.

When is IMAC's next earnings date?

IMAC is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for IMAC.

How were IMAC's earnings last quarter?

IMAC Holdings, Inc. (NASDAQ:IMAC) announced its earnings results on Friday, August, 14th. The company reported ($0.19) earnings per share for the quarter. The business had revenue of $2.57 million for the quarter. IMAC had a negative return on equity of 85.82% and a negative net margin of 46.65%.
View IMAC's earnings history.

What price target have analysts set for IMAC?

2 brokers have issued 1 year price targets for IMAC's shares. Their forecasts range from $4.50 to $4.50. On average, they anticipate IMAC's share price to reach $4.50 in the next year. This suggests a possible upside of 508.1% from the stock's current price.
View analysts' price targets for IMAC.

Are investors shorting IMAC?

IMAC saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 178,100 shares, an increase of 21.7% from the August 31st total of 146,400 shares. Based on an average daily volume of 262,400 shares, the days-to-cover ratio is presently 0.7 days. Approximately 2.5% of the shares of the company are short sold.
View IMAC's Short Interest.

Who are some of IMAC's key competitors?

Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), Hanger (HNGR), Aesthetic Medical International Holdings Group (AIH), AAC (AAC), Biocorrx (BICX), AAC (AACH) and Ceres Ventures (CEVE).
View all competitors.

What other stocks do shareholders of IMAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include VBI Vaccines (VBIV), Biocept (BIOC), Energy Transfer (ET), Ibio (IBIO), McEwen Mining (MUX), Opko Health (OPK), Advanced Micro Devices (AMD), Amarin (AMRN), Aytu BioScience (AYTU) and BioNano Genomics (BNGO).

Who are IMAC's key executives?

IMAC's management team includes the following people:

Mr. Jeffrey S. Ervin M.B.A., Chairman & CEO (Age 43, Pay $239.88k)
Ms. Sheri Gardzina CPA, CPA, Interim CFO & Corp. Sec. (Age 52, Pay $162.04k)
Dr. Matthew C. Wallis, COO & Director (Age 46, Pay $257.27k)
Mr. Jeff Ervin, Chief Exec. Officer

When did IMAC IPO?

(IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

How do I buy shares of IMAC?

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $0.74.

How big of a company is IMAC?

IMAC has a market capitalization of $8.76 million and generates $15.13 million in revenue each year. IMAC employs 108 workers across the globe.

What is IMAC's official website?

The official website for IMAC is www.imacregeneration.com.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]

This page was last updated on 10/19/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings